ImmuCell Plans to Boost First Defense Capacity to 5-6 Million Units, Strengthens U.S. Market Share

ImmuCell Corporation, a biotech company, plans to boost its First Defense capacity to 5-6 million units. This move aims to strengthen its market share in the U.S. The company's successful year has included hiring a new management team, expanding manufacturing capacity, resolving a multiyear backorder, and shifting its strategic focus to maximize shareholder value from the First Defense product.